文献速递妇科

过氧化物酶体增殖物激活受体γ辅激活因子1α介导通路可能成为子宫内膜异位症的治疗靶点

Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis.
PubMed 文献 · Hum Reprod · 2019-01-01

病例对照生物学研究,使用23例卵巢子宫内膜异位囊肿(OE)和10例无OE女性的子宫内膜细胞与组织,发现PGC-1α过表达以时间依赖方式促进OESC增殖(P<0.01 vs 对照)但不促进NESC,并刺激芳香化酶、IL-6/IL-8及抗凋亡因子表达;HX531可抑制上述效应。

要点

  • PGC-1α过表达促进OESC增殖(P<0.01 vs 对照),对NESC无此作用。
  • PGC-1α刺激芳香化酶(P<0.01)及IL-6/IL-8 mRNA表达(各P<0.05 vs 对照)。
  • HX531抑制PGC-1α诱导的增殖、芳香化酶/IL-6/IL-8/survivin mRNA表达(各P<0.05 vs 对照),呈剂量依赖(P<0.01)。

核心结论

  • PGC-1α在子宫内膜异位组织的炎症和细胞增殖中起关键作用,可能参与子宫内膜异位症的发生发展。
  • 在OESC中,PGC-1α刺激细胞增殖并参与局部雌激素生物合成、炎症和凋亡,HX531可抑制这些效应。
  • HX531仅抑制OESC而非NESC中PGC-1α诱导的增殖,提示PGC-1α-RXRα轴可能在促进子宫内膜异位症中起关键作用。
  • 这是首次报道PGC-1α与凋亡抑制蛋白在子宫内膜异位症中的关系。
  • 基于这些发现,PGC-1α介导的通路可能成为子宫内膜异位症分子治疗的潜在靶点。

研究设计与样本

  • 病例对照生物学研究,使用23例卵巢子宫内膜异位囊肿(OE)女性和10例无OE女性的子宫内膜细胞与组织。
  • 分离并培养异位子宫内膜异位症和在位子宫内膜基质细胞(SCs)。
  • 通过过表达或siRNA敲低PGC-1α,采用实时PCR和蛋白质印迹检测表达,Cell Counting Kit-8(WST-8)法检测细胞增殖,荧光素酶报告基因法评估转录活性。

主要发现

  • PGC-1α过表达以时间依赖方式促进OESC增殖(P<0.01 vs 对照),但不促进NESC增殖。
  • PGC-1α刺激芳香化酶(P<0.01 vs 对照)及IL-6/IL-8 mRNA表达(各P<0.05 vs 对照),并导致IκB磷酸化蛋白表达及凋亡抑制因子XIAP和survivin mRNA上调(各P<0.05 vs 对照)。
  • HX531(选择性RXRα拮抗剂)以剂量依赖方式抑制PGC-1α诱导的细胞增殖(P<0.05 vs 对照)、芳香化酶/IL-6/IL-8/survivin mRNA表达(各P<0.05 vs 对照)及PGC-1α转录报告活性(P<0.01 vs 对照)。
  • HX531下调OESC中PGC-1α诱导的芳香化酶启动子PI.3-II转录本;PGC-1α敲低降低芳香化酶、IL-6/IL-8及抗凋亡因子mRNA表达(各P<0.05 vs 对照)。
  • 用于量化RXRα状态的Histogram评分在OE组织中显著高于NE组织(P<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本研究仅纳入OE组织,未包括腹膜型和深部浸润型子宫内膜异位组织,因此这些发现可能不能推广至其他类型的子宫内膜异位症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is a peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α)-mediated pathway involved in the development of endometriosis? SUMMARY ANSWER: PGC-1α plays critical roles in inflammation and cell proliferation of endometriotic tissues and may be involved in the development of endometriosis. WHAT IS KNOWN ALREADY: Expression levels of PGC-1α are higher in ovarian endometrioma (OE) than normal endometrium (NE). PGC-1α also stimulates aromatase activity and promotes local estrogen biosynthesis in OE. STUDY DESIGN, SIZE, DURATION: This is a case-controlled biological study using endometrial cells and tissues derived from 23 women with, and 10 women without, OE. PARTICIPANTS/MATERIALS, SETTING, METHODS: Ectopic endometriotic and eutopic endometrial stromal cells (SCs) were isolated and maintained in culture. PGC-1α was either overexpressed in the cells or knocked down using siRNA. The expression of PGC-1α and other factors during endometriosis was examined using real-time PCR and western blotting, cell proliferation was measured using Cell Counting Kit-8 (WST-8) assays and transcriptional activity was assessed using luciferase reporter assays. MAIN RESULTS AND THE ROLE OF CHANCE: PGC-1α overexpression promoted the proliferation of OESCs in a time-dependent manner (P < 0.01 versus control) but not NESCs. PGC-1α stimulated aromatase (P < 0.01 versus control) and interleukin (IL)-6/IL-8 mRNA expression levels (P < 0.05 versus control for each) and led to inhibitor kappa B phosphorylation protein expression and upregulation of the apoptosis inhibitors X-linked inhibitor of apoptosis protein and survivin at mRNA level (P < 0.05 versus control for each). HX531, a selective retinoid-X receptor-α (RXRα) antagonist, suppressed the PGC-1α-induced cell proliferation (P < 0.05 versus control), aromatase/IL-6/IL-8/survivin mRNA expression (P < 0.05 versus control for each) and transcription reporter activity of PGC-1α in a dose-dependent manner (P < 0.01 versus control). Moreover, HX531 downregulated PGC-1α-induced aromatase-promoter PI.3-II transcripts in OESCs, and PGC-1α knockdown reduced aromatase, IL-6/IL-8 and antiapoptotic factors mRNA expression (P < 0.05 versus control for each). Notably, the Histogram score, which was used for quantifying RXRα status, was markedly higher in OE than in NE tissue (P < 0.01). LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Only OE tissues were included in this study, while peritoneal and deep infiltrating endometriotic tissues were not. Therefore, these findings might not be generalized to other types of endometriosis. WIDER IMPLICATIONS OF THE FINDINGS: In OESC, PGC-1α stimulated cell proliferation and was involved in local estrogen biosynthesis, inflammation and apoptosis, and these effects of PGC-1α were inhibited by HX531. The suppression of PGC-1α-induced proliferation by HX531 in OESCs but not NESCs suggests that the PGC-1α-RXRα axis could play critical roles in promoting endometriosis. This is the first report of a relationship between PGC-1α and inhibitor of apoptosis proteins in endometriosis. Based on these findings, the PGC-1α-mediated pathway could represent a potential target in molecular therapy of endometriosis. STUDY FUNDING/COMPETING INTEREST(S): The study is supported in part by Grants-in-Aid for Scientific Research (15 K10681 and 15 K10726) from the Ministry of Education, Culture, Sports, Science, and Technology (Japan). The authors have no conflicts of interest to disclose.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kataoka H, Mori T, Okimura H, et al. Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis. Hum Reprod. 2019. PMID: 31119261. doi:10.1093/humrep/dez067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。